{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T21:01:40Z","timestamp":1709758900147},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s12185-014-1707-7","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T14:50:51Z","timestamp":1417531851000},"page":"405-410","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS)"],"prefix":"10.1007","volume":"101","author":[{"given":"Joanna","family":"Rupa-Matysek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Lewandowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Wojtasi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzena Liliana","family":"Wojtaszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ksenia","family":"Bykowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieczys\u0142aw","family":"Komarnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,29]]},"reference":[{"issue":"25","key":"1707_CR1","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","volume":"117","author":"A Tiede","year":"2011","unstructured":"Tiede A, Rand JH, Budde U, Ganser A, Federici AB. How I treat the acquired von Willebrand syndrome. Blood. 2011;117(25):6777\u201385.","journal-title":"Blood"},{"key":"1707_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0033-1334867","volume":"39","author":"AB Federici","year":"2013","unstructured":"Federici AB, Budde U, Castaman G, Rand JH, Tiede A. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Semin Thromb Hemost. 2013;39:191\u2013201.","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"1707_CR3","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","volume":"106","author":"AV Jones","year":"2005","unstructured":"Jones AV, Kreil S, Zoi K, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood. 2005;106(6):2162\u20138.","journal-title":"Blood"},{"issue":"4","key":"1707_CR4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/leu.2011.258","volume":"26","author":"G Finazzi","year":"2012","unstructured":"Finazzi G, Carobbio A, Thiele J, et al. Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria. Leukemia. 2012;26(4):716\u20139.","journal-title":"Leukemia"},{"issue":"3","key":"1707_CR5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ejh.12064","volume":"90","author":"YS Chou","year":"2013","unstructured":"Chou YS, Gau JP, Yu YB, et al. Leukocytosis in polycythemia vera and splenomegaly in essential thrombocythemia are independent risk factors for hemorrhage. Eur J Haematol. 2013;90(3):228\u201336.","journal-title":"Eur J Haematol"},{"issue":"6","key":"1707_CR6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0049-3848(99)00196-6","volume":"97","author":"DR Krizek","year":"2000","unstructured":"Krizek DR, Rick ME. A rapid method to visualize von Willebrand factor multimers by using agarose gel electrophoresis, immunolocalization and luminographic detection. Thromb Res. 2000;97(6):457\u201362.","journal-title":"Thromb Res"},{"issue":"2","key":"1707_CR7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-2002-27820","volume":"28","author":"U Budde","year":"2002","unstructured":"Budde U, Drewke E, Mainusch K, Schneppenheim R. Laboratory diagnosis of congenital von Willebrand disease. Semin Thromb Hemost. 2002;28(2):173\u201390.","journal-title":"Semin Thromb Hemost"},{"issue":"15","key":"1707_CR8","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1161\/CIRCULATIONAHA.108.786681","volume":"118","author":"T Tourneau Le","year":"2008","unstructured":"Le Tourneau T, Susen S, Caron C, et al. Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction. Circulation. 2008;118(15):1550\u20137.","journal-title":"Circulation"},{"issue":"24","key":"1707_CR9","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1136\/hrt.2010.217273","volume":"97","author":"J Natorska","year":"2011","unstructured":"Natorska J, Bykowska K, Hlawaty M, et al. Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis. Heart. 2011;97(24):2023\u20138.","journal-title":"Heart"},{"key":"1707_CR10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1213\/ANE.0b013e318236b16a","volume":"114","author":"S Lison","year":"2012","unstructured":"Lison S, Dietrich W, Spannagl M. Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease. Anesth Analg. 2012;114:73\u201381.","journal-title":"Anesth Analg"},{"key":"1707_CR11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1055\/s-0037-1614775","volume":"94","author":"C Sucker","year":"2005","unstructured":"Sucker C, Feindt P, Zotz RB, Stockschlaeder M, Scharf RE. Functional von Willebrand Factor assays are not predictive for the absence of highest-molecular weight von Willebrand Factor multimers in patients with aortic-valve stenosis. Thromb Haemost. 2005;94:465\u20136.","journal-title":"Thromb Haemost"},{"key":"1707_CR12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1538-7836.2008.02909.x","volume":"6","author":"A Tiede","year":"2008","unstructured":"Tiede A, Priesack J, Werwitzke S, et al. Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study. J Thromb Haemost. 2008;6:569\u201376.","journal-title":"J Thromb Haemost"},{"issue":"suppl 2","key":"1707_CR13","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0049-3848(13)70003-3","volume":"130","author":"A Tiede","year":"2012","unstructured":"Tiede A. Diagnosis and treatment of acquired von Willebrand syndrome. Thromb Res. 2012;130(suppl 2):S2\u20136.","journal-title":"Thromb Res"},{"key":"1707_CR14","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.1312148111","volume":"111","author":"SL Etheridge","year":"2014","unstructured":"Etheridge SL, Roh ME, Cosgrove ME, et al. JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms. Proc Nat Acad Sci USA. 2014;111:2295\u2013300.","journal-title":"Proc Nat Acad Sci USA"},{"issue":"1","key":"1707_CR15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3324\/haematol.11653","volume":"93","author":"E Antonioli","year":"2008","unstructured":"Antonioli E, Guglielmelli P, Poli G, et al. Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia. Haematologica. 2008;93(1):41\u20138.","journal-title":"Haematologica"},{"issue":"1","key":"1707_CR16","first-page":"21","volume":"8","author":"A Patriarca","year":"2010","unstructured":"Patriarca A, Pompetti F, Malizia R, et al. Is the absence of JAK2 mutation a risk factor for bleeding in essential thrombocythemia? An analysis of 106 patients. Blood Transfus. 2010;8(1):21\u20137.","journal-title":"Blood Transfus"},{"issue":"6","key":"1707_CR17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ajh.23417","volume":"88","author":"A Tefferi","year":"2013","unstructured":"Tefferi A. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management. Am J Hematol. 2013;88(6):507\u201316.","journal-title":"Am J Hematol"},{"issue":"2","key":"1707_CR18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2141.2011.08858.x","volume":"156","author":"F Palandri","year":"2012","unstructured":"Palandri F, Polverelli N, Catani L, et al. Bleeding in essential thrombocythaemia: a retrospective analysis on 565 patients. Br J Haematol. 2012;156(2):281\u20134.","journal-title":"Br J Haematol"},{"issue":"2","key":"1707_CR19","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","volume":"141","author":"Y Falck-Ytter","year":"2012","unstructured":"Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):e278S\u2013325S.","journal-title":"Chest"},{"issue":"2","key":"1707_CR20","first-page":"345","volume":"84","author":"AB Federici","year":"2000","unstructured":"Federici AB, Rand JH, Bucciarelli P, et al. Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost. 2000;84(2):345\u20139.","journal-title":"Thromb Haemost"},{"issue":"8","key":"1707_CR21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MBC.0b013e3280100d1e","volume":"17","author":"M Franchini","year":"2006","unstructured":"Franchini M, Veneri D, Lippi G. The use of recombinant activated factor VII in congenital and acquired von Willebrand disease. Blood Coagul Fibrinolysis. 2006;17(8):615\u20139.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"1707_CR22","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/art.38375","volume":"66","author":"P Wu","year":"2014","unstructured":"Wu P, Holguin N, Silva MJ, et al. Early response of mouse joint tissue to noninvasive knee injury suggests treatment targets. Arthritis Rheumatol. 2014;66(5):1256\u201365.","journal-title":"Arthritis Rheumatol"},{"issue":"suppl 2","key":"1707_CR23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00292-008-1036-9","volume":"29","author":"L Morawietz","year":"2008","unstructured":"Morawietz L, Fernahl G, Krenn V. Differential diagnosis of synovitis. Pathologe. 2008;29(suppl 2):218\u201322.","journal-title":"Pathologe"},{"issue":"7","key":"1707_CR24","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.joca.2011.04.011","volume":"19","author":"JS Lewis","year":"2011","unstructured":"Lewis JS, Hembree WC, Furman BD, Tippets L, Cattel D, Huebner JL, Little D, DeFrate LE, Kraus VB, Guilak F, Olson SA. Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse knee. Osteoarthritis Cartilage. 2011;19(7):864\u201373.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"1707_CR25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0749-8063(95)90094-2","volume":"11","author":"DJ Ogilvie-Harris","year":"1995","unstructured":"Ogilvie-Harris DJ, Weisleder L. Arthroscopic synovectomy of the knee: is it helpful? Arthroscopy. 1995;11(1):91\u20135.","journal-title":"Arthroscopy"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1707-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1707-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1707-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T11:16:30Z","timestamp":1690715790000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1707-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,29]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["1707"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1707-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,29]]}}}